Skip to main content

Prashant Girinath, Ph.D. is a shareholder in the Intellectual Property and Technology group. Prashant has designed and implemented IP strategy for companies through all strata, from startups to venture backed and public companies. He helps clients with their legal needs and IP strategy from inception through public offerings and exits. Prashant works with clients on both the sell-side and the buy-side of M&A.

Prashant has represented investors and companies in IP related matters in financings in all stages from pre-seed to venture capital or private equity rounds and pre-IPO crossover rounds.

Prashant has obtained thousands of patents for companies and aggressively developed complex IP portfolios with dominant patent positions that have helped facilitate significant partnering outcomes, especially in the life sciences. He has also represented many companies in licensing and partnering transactions.

Prashant’s experience working on IP related matters for hundreds of companies and investors and co-founding biotech companies helps him visualize and capture strategic opportunities at the intersection of technology and IP.


  • Therapeutics
  • Gene editing
  • Antibody
  • CAR-T
  • Paragraph IV
  • Chemistry
  • Pharmaceutical sciences
  • Peptides
  • Protein
  • Material science


Recognition & Leadership

  • Listed, The Best Lawyers in America, "Ones to Watch," Patent Law, 2024
  • Listed, The Legal 500 United States, M&A/Corporate and Commercial > Venture Capital and Emerging Companies, "Recommended Lawyer," 2022
  • Listed, Boston magazine, "Top Lawyers - Intellectual Property Rights," 2022


  • J.D., Georgetown University Law Center
  • Ph.D., Medicinal Chemistry, State University of New York at Buffalo
  • B.E., Chemical Engineering, University of Mumbai
  • Massachusetts
  • Hindi
  • Tamil